Reply to G. Spitzer and M.A. Socinski
- PMID: 25584009
- DOI: 10.1200/JCO.2014.58.5307
Reply to G. Spitzer and M.A. Socinski
Comment on
-
Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.J Clin Oncol. 2014 Jun 20;32(18):1874-81. doi: 10.1200/JCO.2013.54.4270. Epub 2014 May 19. J Clin Oncol. 2014. PMID: 24841982 Review. No abstract available.
-
Alternative strategy to achieve increased overall survival and better quality of life in patients with second-line advanced non-small-cell lung cancer.J Clin Oncol. 2015 Feb 10;33(5):522-3. doi: 10.1200/JCO.2014.58.1603. Epub 2015 Jan 12. J Clin Oncol. 2015. PMID: 25584003 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
